NOACs May Be Better Choice for Patients With A-Fib and DM
For patients with atrial fibrillation (AF) and diabetes mellitus (DM), non-vitamin K antagonist oral anticoagulants (NOACs) are associated...
February 14, 2022
by drugs.com
NICE updates guideline on atrial fibrillation
The UK’s National Institute for Health and Care Excellence has published an updated clinical guideline on the diagnosis and management of atrial fibrillation (AF) addressing several areas of new evidence.
April 28, 2021
by pharmatimes
Daiichi Sankyo inks digital partnership for atrial fibrillation
Daiichi Sankyo has signed a collaborative agreement with three technology partners to improve the detection and diagnosis of atrial fibrillation (AF) in the UK.
March 24, 2021
by pharmatimes
Trial to Assess Pulsed Field Ablation System for AFib Receives FDA Conditional Approval
FARAPULSE announced the U.S. Food and Drug Administration (FDA) conditionally approved the Company's Investigational Device Exemption (IDE) application to initiate its U.S. pivotal ADVENT trial to evaluate the safety and effectiveness of its ...
December 18, 2020
by americanpharmaceuticalreview
Obesity Mediates Response to Antiarrhythmic Drugs in A-Fib
Obesity may cause a differential response to antiarrhythmic drugs (AADs) used to suppress atrial fibrillation (AF), according to a study published online in JAMA Cardiology.
December 18, 2019
by drugs
Having HIV May Heighten Stroke Risk
People with HIV have a greatly increased risk of a common heart rhythm disorder that's a leading cause of stroke, a new study shows.
September 10, 2019
by drugs
Anniversary of the pivotal RE-LY® trial marks a decade of innovation for stroke prevention in AF patients
Boehringer Ingelheim today announces the ten-year anniversary of the RE-LY® trial publication(1-3) recognising the contribution made in the decade since by patients...
September 2, 2019
by worldpharmanews
Correvio Resubmits Brinavess (vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation
Correvio Resubmits Brinavess (vernakalant) New Drug Application to U.S. FDA for the Treatment of Patients with Recent Onset Atrial Fibrillation.
June 26, 2019
by drugs
Risk Factors ID'd for Atrial Fibrillation With Type 1 Diabetes
Risk Factors ID'd for Atrial Fibrillation With Type 1 Diabetes.
June 21, 2019
by drugs
Catheter Ablation Tops Drug Therapy for A-Fib in Heart Failure
Catheter ablation is better than drug therapy for the treatment of atrial fibrillation (AF) in patients with heart failure, according to a review published online Dec. 25 in the Annals of Internal Medicine.....
January 2, 2019
by drugs
High Sodium Intake Associated With New Atrial Fibrillation
Sodium intake is associated with the long-term risk of new-onset atrial fibrillation (AF), according to a study recently published in the Annals of Medicine.....
December 29, 2018
by drugs
Anticoagulant drugs appear to reduce the risk of stroke in patients with AF
Blood-thinning drugs not only reduce the risk of stroke in patients with AF but are also associated with a significant reduction in the risk of dementia…
October 26, 2017
by europeanpharmaceuticalreview